News
Brief news reports on Tuberculosis
By
Johnson & Johnson
Published: Sept. 17, 2014, 8:14 p.m.·
Tags:
Drug-resistant TB,
Pediatrics
New collaboration will help address significant global unmet needs in pediatric drug-resistant tuberculosis (DR-TB) treatment and optimize use of existing DR-TB treatments
Read More →
By
Helen R. Stagg et al.
Published: Sept. 16, 2014, 8:25 p.m.·
Tags:
Latent TB
In many countries with a low incidence of tuberculosis (TB), many new cases emerge as a result of reactivation of latent TB infection (LTBI), which is often acquired in high-incidence areas or from recent exposure in occasional outbreaks. Therefore, such countries have had a renewed interest in LTBI screening and treatment, generally for groups at particularly high risk for reactivation, such as contacts of patients with pulmonary TB, persons who are immunocompromised, and migrants from high-incidence areas.
Read More →
By
Md Sazedul Islam
Published: Sept. 15, 2014, 8:50 p.m.·
Tags:
TB epidemiology,
TB programs
Shahidul Islam (45), a resident of Chak Shyamnagar village of Meherpur Sadar upazila, had been suffering from cold, fever, chest pain and weight loss for a month. He took treatment from a local private clinic and then from a hospital in Khulna. He had to spend a lot of money, but his problem was not solved.
Read More →
By
Jake Miller
Published: Sept. 15, 2014, 8:35 p.m.·
Tags:
Global TB response
In a new collaborative project, researchers and clinicians hope to put the pieces together to solve the puzzle of global TB.
Read More →
By
International Union Against Tuberculosis and Lung Disease
Published: Sept. 12, 2014, 8:52 p.m.·
Tags:
Global TB response
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
Read More →
By
Sveta McGill
Published: Sept. 12, 2014, 8:19 p.m.·
Tags:
HIV coinfection
TB is both the most significant AIDS-related disease and the leading cause of death in PLHIV in Ukraine. The dual epidemics of TB and HIV continue to have significant impacts in the country, and pose multiple challenges for effective management and treatment of people living with HIV and TB.
Read More →
By
Mark Mascolini
Published: Sept. 10, 2014, 11:57 p.m.·
Tags:
HIV coinfection
Most immune-related cytokine levels before antiretroviral therapy (ART) began were higher in Botswana patients who died soon after starting ART than in people who did not die [1]. In contrast, pre-ART cytokine levels were lower in people with TB immune reconstitution inflammatory syndrome (IRIS) after starting ART than in the control group of survivors without TB-IRIS.
Read More →
By
Antigone Barton
Published: Sept. 10, 2014, 11:55 p.m.·
Tags:
Drug-resistant TB
Read More →
By
Mark Mascolini
Published: Sept. 10, 2014, 11:52 p.m.·
Tags:
Pediatrics,
Vaccines
Meta-analysis of 14 studies indicated that BCG vaccination protects against Mycobacterium tuberculosis infection in children under 16 years old, while a six-study analysis determined that the vaccine protects and against progression from infection to active disease.
Read More →
By
civil society
Published: Sept. 10, 2014, 11:51 p.m.·
Tags:
Advocacy,
Access,
Drug-resistant TB
Several organizations and individuals working on TB appeal to Janssen to lower bedaquiline's price for all non-high-income countries.
Read More →
Page 615 of 878 · Total posts: 10
←First
614
615
616
Last→